A Study of SHR-1826 Monotherapy or in Combination With Immunotherapy in the Treatment of Advanced Hepatocellular Cancer
Clinical trial NCT06935175 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06935175
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2027-05-31
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.